Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy.

Persons

Aaron Seth Kesselheim

Venue / Journal

JAMA

Date

Tue, 12/13/2016 - 12:00

Additional Journal Information

316(22):2357-2358

Authors

Kesselheim AS, Avorn J.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/27775756